Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.1400
+0.0900 (4.39%)
NASDAQ · Last Trade: Feb 26th, 3:23 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors